SMAD3 and type 2 diabetes mellitus: In this study, we observed increased TGF-β and p-Smad3 in C3a-treated HRGECs and T2DM rats, suggesting that C3a plays an important role in the activation of TGF-β/Smad3 signaling and is a potential inducer of renal fibrosis.